X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7097) 7097
Publication (472) 472
Book Review (167) 167
Book / eBook (165) 165
Book Chapter (66) 66
Newsletter (26) 26
Newspaper Article (19) 19
Magazine Article (13) 13
Conference Proceeding (10) 10
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5993) 5993
female (3490) 3490
male (3467) 3467
administration, oral (3133) 3133
index medicus (2740) 2740
adult (2419) 2419
middle aged (2326) 2326
aged (1603) 1603
treatment outcome (1371) 1371
adolescent (1032) 1032
prednisone - administration & dosage (1015) 1015
prednisone - therapeutic use (937) 937
therapy (885) 885
corticosteroids (860) 860
child (828) 828
dentistry, oral surgery & medicine (761) 761
oncology (666) 666
pharmacology & pharmacy (649) 649
surgery (638) 638
follow-up studies (628) 628
care and treatment (616) 616
prednisone (590) 590
drug therapy, combination (588) 588
double-blind (575) 575
drug therapy (550) 550
glucocorticoids - administration & dosage (547) 547
retrospective studies (532) 532
drug administration schedule (529) 529
medicine & public health (519) 519
dentistry (517) 517
time factors (501) 501
children (498) 498
immunology (495) 495
aged, 80 and over (484) 484
dose-response relationship, drug (480) 480
glucocorticoids - therapeutic use (480) 480
child, preschool (479) 479
immunosuppressive agents - therapeutic use (475) 475
risk factors (469) 469
animals (463) 463
chemotherapy (463) 463
health aspects (456) 456
pediatrics (452) 452
cancer (444) 444
management (435) 435
dermatology (420) 420
medicine, general & internal (411) 411
transplantation (409) 409
asthma - drug therapy (406) 406
anti-inflammatory agents - therapeutic use (405) 405
hematology (399) 399
double-blind method (390) 390
analysis (387) 387
asthma (386) 386
rheumatology (381) 381
steroids (374) 374
diagnosis (368) 368
antineoplastic combined chemotherapy protocols - therapeutic use (362) 362
anti-inflammatory agents - administration & dosage (359) 359
young adult (355) 355
research (354) 354
diagnosis, differential (353) 353
prospective studies (352) 352
injections, intravenous (346) 346
disease (344) 344
abridged index medicus (336) 336
recurrence (335) 335
severity of illness index (329) 329
gastroenterology & hepatology (327) 327
efficacy (324) 324
adrenal cortex hormones - therapeutic use (317) 317
immunosuppressive agents - administration & dosage (308) 308
clinical trials (296) 296
infant (285) 285
patients (282) 282
allergy (279) 279
dosage and administration (275) 275
prognosis (273) 273
trial (271) 271
glucocorticoids - adverse effects (268) 268
dexamethasone (263) 263
acute disease (262) 262
pharmacokinetics (258) 258
glucocorticoids (256) 256
internal medicine (255) 255
prednisone - adverse effects (255) 255
methylprednisolone - administration & dosage (253) 253
adrenal cortex hormones - administration & dosage (250) 250
prevention (246) 246
infusions, intravenous (240) 240
prednisolone (238) 238
administration, inhalation (237) 237
cyclophosphamide - administration & dosage (235) 235
ophthalmology (233) 233
prednisolone - administration & dosage (233) 233
respiratory system (232) 232
pathology (230) 230
remission induction (224) 224
clinical trials as topic (223) 223
immunosuppressive agents - adverse effects (218) 218
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
UTL at Downsview - May be requested (69) 69
Dentistry (Harry R Abbott) - Stacks (46) 46
Gerstein Science - Stacks (37) 37
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (27) 27
Dentistry (Harry R Abbott) - Withdrawn (27) 27
Dentistry (Harry R Abbott) - Circulation Desk (5) 5
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Dentistry (Harry R Abbott) - May be requested (3) 3
OISE - Stacks (3) 3
UofT at Mississauga - Stacks (3) 3
Lakeridge Health Sciences - Oshawa (2) 2
Online Resources - Online (2) 2
Robarts - Stacks (2) 2
Scarborough Hospital - Birchmount (2) 2
Chemistry (A D Allen) - Stacks (1) 1
Dentistry (Harry R Abbott) - Course Reserves (1) 1
Dentistry (Harry R Abbott) - Mending (1) 1
Dentistry (Harry R Abbott) - Searching (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
New College (Ivey) - Stacks (1) 1
Scarborough Hospital - General (1) 1
St Josephs Health Centre - Stacks (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Toronto East General Hospital - Stacks (1) 1
University College (Laidlaw) - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7129) 7129
French (73) 73
Spanish (63) 63
German (58) 58
Polish (16) 16
Portuguese (14) 14
Japanese (10) 10
Chinese (9) 9
Italian (8) 8
Arabic (6) 6
Danish (4) 4
Russian (4) 4
Dutch (2) 2
Hebrew (2) 2
Turkish (2) 2
Bulgarian (1) 1
Czech (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 10, pp. 934 - 941
Journal Article
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2014, Volume 32, Issue 7, pp. 634 - 640
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2007, Volume 25, Issue 28, pp. 4459 - 4465
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9747, pp. 1147 - 1154
Summary Background Cabazitaxel is a novel tubulin-binding taxane drug with antitumour activity in docetaxel-resistant cancers. We aimed to compare the efficacy... 
Internal Medicine | EVERY 3 WEEKS | MEDICINE, GENERAL & INTERNAL | PAIN | SOLID TUMORS | END-POINTS | TAXANE | CHEMOTHERAPY | ESTRAMUSTINE | Prostatic Neoplasms - metabolism | Mitoxantrone - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Drug Resistance, Neoplasm | Male | Prostatic Neoplasms - immunology | Antineoplastic Agents, Hormonal - therapeutic use | Treatment Failure | Neutropenia - chemically induced | Mitoxantrone - adverse effects | Prostatic Neoplasms - drug therapy | Taxoids - adverse effects | Prostatic Neoplasms - pathology | Prednisone - administration & dosage | Prednisone - adverse effects | Drug Administration Schedule | Administration, Oral | Kaplan-Meier Estimate | Treatment Outcome | Disease Progression | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Biomarkers, Tumor - blood | Disease-Free Survival | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Androgen Antagonists - therapeutic use | Aged | Infusions, Intravenous | Pain Measurement | Dosage and administration | Prednisone | Research | Drug therapy | Prostate cancer | Mitoxantrone hydrochloride | Studies | Chemotherapy | Medical imaging | Physicians | Family medical history | Radiation therapy | Clinical medicine | Cancer therapies
Journal Article
Blood, ISSN 0006-4971, 09/2010, Volume 116, Issue 9, pp. 1405 - 1412
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 9, pp. 1019 - 1026
Summary Background Present first-line therapy for diffuse large B-cell lymphoma, a subtype of non-Hodgkin lymphoma, is rituximab, cyclophosphamide,... 
Hematology, Oncology and Palliative Medicine | THERAPY | OLDER PATIENTS | ONCOLOGY | FEBRILE NEUTROPENIA | PCI-32765 | CHRONIC LYMPHOCYTIC-LEUKEMIA | CLASSIFICATION | RANDOMIZED CONTROLLED-TRIAL | TARGETING BTK | ELDERLY-PATIENTS | CHEMOTHERAPY | Doxorubicin - therapeutic use | Pyrazoles - therapeutic use | Prognosis | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Dose-Response Relationship, Drug | Young Adult | Non-Randomized Controlled Trials as Topic | Aged, 80 and over | Adult | Female | Lymphoma, Non-Hodgkin - drug therapy | Pyrazoles - adverse effects | Severity of Illness Index | Antigens, CD20 - immunology | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Drug Administration Schedule | Administration, Oral | Rituximab | Survival Rate | Treatment Outcome | Lymphoma, Large B-Cell, Diffuse - mortality | Disease-Free Survival | Lymphoma, Large B-Cell, Diffuse - diagnosis | Maximum Tolerated Dose | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Vincristine - therapeutic use | Vincristine - adverse effects | Aged | Lymphoma, Non-Hodgkin - mortality | Antigens, CD20 - drug effects | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Lymphoma, Non-Hodgkin - diagnosis | Care and treatment | Anthracyclines | Cyclophosphamide | Prednisone | Corticosteroids | Tumors
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2004, Volume 351, Issue 15, pp. 1513 - 1520
Journal Article